iipta1 portfolio report (2008-2013) a patent portfolio is generated and analyzed of johnson &...

www.iipta.com

IIPTALaunch a Career. Be Awesome

www.iipta.com1 Portfolio Report (2008-2013)

A patent portfolio is generated and analyzed of Johnson & Johnson group companies from year 2008 to 2013. Only new inventions which were filed during these years are considered for further analysis in this report. The patents were searched in

WIPO, USPTO and Patent lens databases. 328 Patent were selected for final analysis to explore the field of innovation by Johnson group. As Johnson group is very big only those division which operates under Johnson & Johnson name is considered in this report. Vision Care, Consumer care and some few subsidiaries mainly operates under trade name Johnson & Johnson. The trend of patent filing during these years, Geographical Scope of the inventions, IPC classifications, and top inventors is analyzed Technology mind maps are represented to provide an idea about the recent inventions from Johnson group which includes applications of inventions, products and process involved. After preliminary taxonomy, SWOT and Competitive Intelligence analysis is done to observe the internal positive, internal negative, external positive and external negative factors which can play important role for future business trend of Johnson group. A competitive intelligence chart is prepared for easy understanding of potential contenders of Johnson group on the basis of product ranges, finances, research and development and future plans.

Abstract

www.iipta.com 2Portfolio Report (2008-2013)

1. Introduction

1.1 Company overview

1.2 Milestones by Johnson & Johnson

1.3 Company Structure

2. Product Details

3. Patent Search Methodology

4. Results and Statistical Analysis

5. SWOT Analysis

6. Competitive Intelligence

7. Conclusion

8. References

3

3

5

7

15

20

21

35

38

44

46

Contents


1.1.2 Company FeaturesThe world’s largest and most diverse medical devices and Diagnostics Company

The world’s sixth- largest biologics company

The world’s sixth-largest consumer health company

The world’s eighth-largest pharmaceuticals company

The Medical Devices and Diagnostics segment produces a broad range of innovative products used primarily by health care professionals in the fields of orthopedics, neurovascular, surgery, vision care, diabetes care, infection prevention, diagnostics, cardiovascular disease, sports medicine, and aesthetics.

The Pharmaceutical segment’s broad portfolio focuses on unmet medical needs across several therapeutic areas: cardiovascular & metabolism, immunology, infectious diseases &vaccines, neuroscience & pain, and oncology.

The Consumer segment includes a broad range of products used in the baby care, skin care, oral care, wound care and women’s health care fields, as well as nutritional and over-the-counter pharmaceutical products, and wellness and prevention platforms.

1.1 COMPANY OVERVIEWJohnson & Johnson (J&J) is a US-based multinational company founded in 1886. Company is activated in consumer healthcare, medical devices and diagnostics and pharmaceuticals. J&J’s brands include numerous household names of medications and first aid supplies. Among its well known consumer products are the Band-Aid brand lines of bandages, Tylenol medications, Johnson’s baby products, Neutrogena skin and beauty products, clean & clear facial wash and acuvue contact lenses. [1]

1. Introduction

1.1.1 Achievements» According to Harris Interactive (Market

Research firm) J&J got ranked top for seven consecutive years up to 2005 [2]

» J&J was the first corporation awarded

by Benjamin Franklin Award for Public Diplomacy by the US States department in 2005 for its funding of international education programs. [3]

» J&J was ranked as the world’s most

respected company by Barron’s Magazine in 2008.


1.1.3 Awards & Recognitions: [33]

2013

Thomson Reuters: Named J&J as one of its top 100 global innovators for 2013

Working Mother Magazine: J&J as one of the best companies for working others in 2013.

Interbrand listed J&J number six on their special “Best of the Best” for strides made in diversity efforts.

Harris Interactive: J&Jimproved its ranking to No. 5, up from No.07 in 2012 in the Harris interactive 2013Reputation Quotient Survey list.

Janssen Spain (Janssen-Cilag Ltd.) was recognized by the Great Place to Work® Institute as one of the Best Workplaces España 2013.

J&J is the highest-ranking healthcare company among the CNN Money 2013 100 Top MBA Employers, and it is #16 among all companies on the list.

2012

J&J was ranked no. 2 byinterband’s 2012 Best Global Green Brands report

J&J ranked No. 9 among the top 20 companies in forbes 7th annual “Best Companies for Leadership” survey.

In 2012 J&J was again named to FORTUNE magazine’s list of the World’s Most Admired Companies.

J&J was awarded the 2012 Corporate Health Achievement Award (CHAA) by AmericanCollege of Occupational and Environmental Medicine (ACOEM).

J&J was ranked No. 11 by Diversity Inc magazine on its “2012DiversityInc Top 50 Companies for Diversity” list.

J&J was named one of the 10 Best U.S. Corporations forVeteran-Owned Businesses for 2012 by (NaVOBA).

J&J was ranked No. 2 by Interbrand’s 2012 Best Global Green Brands report in recognition of building a green business and effectively communicating sustainable practices in the global marketplace.

2011

J&J ranked No. 5 on forbes list of America’s top 10 green companies.

According to annual corporate reputation survey conducted by Harris Interactive and Reputation insitute, J&J was recognised for having the 2nd best corporate reputation in America.

S T E L A R A ® (ustekinumab), from Janssen Biotech, Inc., was awarded the prestigious 2011 Prix Galien USA Award in the category of Best Biotechnology Product.

J&J was awarded the United Nations 2011 Humanitarian of the Year Award for our leading role in its Healthy Mother, Healthy Child initiative.


1.2 MILESTONES BY JOHNSON & JOHNSON

Year

1886

1888

1894

1896-97

1898

1901

1921

1931

1937

1943

Achievements

Three brothers, Robert wood Johnson, James Wood Johnson and Edward Mead Johnson found Johnson and Johnson in New Brunswick, New Jersy, U.S.The company publishes “modern methods of antiseptic wound treatment”, which quickly becaomes one of the standard teaching texts for antiseptic surgery.

J&J pioneers the first commercial first aid kits. The initial kits are designed to help railroad workers, but soon become the standard in treating injuries

J&J launches maternity kits to make childbirth safer for mothers and babies. JOHNSON’S® Baby Powder goes on the market. Its success leads to theCompany’s heritage Baby business

Manufacture the first produced sanitary protection products for women.

First produce dental floss to make it affordable so that people can take better care of their teeth

J&J published the first First Aid manuals using proven best practices from leading physicians. The manuals are packaged with the Company’s First Aid Kits.

BAND-AID Brand Adhesive Bandages, invented by employee Earle Dickson in 1920, go on the market. They are the first commercial dressings for small wounds that consumers can apply themselves.

A J&J operating company pioneers family planning products withORTHO-GYNOL, the first prescription contraceptive gel. This was based on the need for trusted family planning products.

Company expands to Argentina and Brazil. Ortho Research Laboratories, Inc. is established in Linden, New Jersey, to make women’s health products.

General Robert Wood Johnson writes Our Credo, which remains the guiding philosophy of J&J.


Year

1944

1954

1959

1961

1963-73

1976-89

1987

1989-2002

Achievements

Dr. Philip Levine, the discoverer of the human rH factor, joins Ortho ResearchLaboratories, creating the beginnings of the worldwide diagnostics business. J&J goes public, with a listing on the New York Stock Exchange.

JOHNSON’S Baby Shampoo with NO MORE TEARS formula enters the market as the first mild and soap-free shampoo designed to be gentle enough to clean babies’ hair but not irritate their eyes.

» J&J acquires McNeil Laboratories in the U.S. and Cilag Chemie, AG in Europe, giving the Company a significant presence in the growing field of pharmaceutical medicines.

» One McNeil product, TYLENOL (acetaminophen) elixir for children, is the first prescription aspirin-free pain reliever. A year later, it becomes available without a prescription and earns status as the pain reliever doctors and pediatricians recommend most.

Janssen Pharmaceutical N.V. Joins the company.

Operating companies launch new treatments for Schizophrenia, family planning and personal care.

The Company enters new areas of health, such as vision care, mechanical wound closure and diabetes management, and opens the first operating companies in China and Egypt.

The vision care business introduces ACUVUE Brand Contact Lenses, the first disposable contact lenses that can be worn for up to a week, thrown away and replaced with a fresh pair. The lenses eliminate the need for cleaning, disinfecting solutions and storage. Later, 1-DAY ACUVUE Brand Contact Lenses become the first daily disposable contact lens.

Neutrogena Corporation, Kodak’s Clinical Diagnostics business, Cordis Corporation and Centocor join the company.


1.3 COMPANY STRUCTURE:J&J has more than 250 companies located in 60 countries around the world. Its Family of Companies is organized into several business segments comprised of franchises and therapeutic categories. In USA J&J is having 127 subsidiaries.

Year

1990

1994

2002

2006

2010

2011

2013

Achievements

Ethicon Endo-Surgery pioneers minimally invasive surgery, which uses very small incisions and helps patients recover faster than with traditional surgery.

The PALMAZ-SCHATZ stent, the first coronary stent, revolutionizes cardiology.Coronary stents keep vessels open so blood can flow to the heart. Later, CordisCorporation introduces the first drug-eluting stent, which helps prevent the arteries from re-clogging

» The Company enters new therapeutic areas such as HIV/AIDS, and health and wellness.

» J&J acquire Tibotec-Virco BVBA to help address the vast unmet needs of patients with HIV/AIDS and other infectious diseases such as tuberculosis.

J&J acquires Pfizer Consumer Healthcare, which brings in heritage consumer brands such as LISTERINE Antiseptic (first formulated in 1879),BENGAY, BENADRYL and more.

The Company supports the United Nations’ Millennium Development Goals to improve the health of mothers and children in developing countries. As a founding sponsor, J&J helps launch the United States’ first free mobile health service, providing health information via text messages for pregnant women and new mothers.

Company completed 125 years.

» 125th Anniversary of company’s fist aid kits.» Opened innovation centers in Boston, MA; Menlo Park, CA; London, UK;

and Shanghai China.


International Subsidiaries

Country

Ireland

Switzerland

United Kingdom

France

Germany

China

Mexico

Belgium

Sweden

Italy

Netherlands

Australia

Spain

Israel

Venezuela

Denmark

Brazil

Austria

Korea

Korea

South Africa

Japan

Hong Kong

No of Subsidiaries

17

17

16

12

11

9

8

8

6

6

6

6

4

3

3

3

3

3

3

3

3

3

3

Country

Portugal

Thailand

Finland

Greece

Poland

Panama

Argentina

Colombia

Peru

Egypt

Hungary

India

Russia

Pakistan

Philippines

Slovenia

Singapore

Malaysia

Czech Republic

Slovakia

Taiwan

Indonesia

No of Subsidiaries

2

2

2

2

2

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1


1. Baby Care

Baby Care division is a leader in baby skin and hair care with products trusted by moms and hospitals for more than 115 years. Along with a growing line of family skin care products, this business unit includes the JOHNSON’S brand with products sold in more than 100 countries around the world. Eg: JOHNSON’S baby intense moisture cream, baby lotion, baby oil etc.

2. Skin & Hair CareJ&J is specialized in bringing science to the art of beauty via innovative technologies across a spectrum of consumer and professional needs with science-based platforms that include clear skin, anti-aging, skin of color and sun care. Eg: Neutrogena, Bebe, Clean & Clear, Roc and Vendome etc.

3. Wound Care and TopicalOffering superior, scientifically proven products from beloved brands in wound care, itch relief, pain relief and germ protection to heal, relieve, and protect so individuals and families can keep doing the things they love. Eg: BAND-Aid, Bengay, Savlon, Neosporin etc.

4. Oral Health CareOffering oral health products that help you clean 100 percent of your mouth through a brush-floss-rinse regimen as well as whitening products that deliver a brighter, more beautiful smile. Eg: Listerine, Listerine Whitening and Rembrandt etc.

5. Women’s HealthInnovative women’s health brands that address the personal health and feminine hygiene needs of their consumers. E.g.:

O.B. Original, O.B. Procomfort etc.

6. Over-The-Counter MedicinesMarketing a broad range of well-known and trusted over-the-counter products around the globe, including pain relievers, allergy medicines, anti-diarrheal medicines, antacids, nasal decongestants, as well as medicines for coughs and colds. Eg: Tylenol, Imodium, Dolormin, Benadryl, Sudafed, Pepcid, Nicorette etc.

7. NutritionalsThe innovative nutritional products such as sweeteners, milk supplements and dietary supplement around the world while giving people the ability to actively manage their own health. E.g.: Splenda, Benecol, Lactaid etc.

1.3.1 Consumer Health Care: The consumer segment includes a broad range of products used in the baby care, skin care, oral care, wound care and women’s

health care fields, as well as nutritional and over-the-counter pharmaceutical products, and wellness and prevention platforms [6]


1.3.1.2 Revenue Generated by Consumer Segment: [32][8]

1.3.2 Medical Devices & Diagnostics:The Medical Devices and Diagnostics segment produces a broad range of innovative products used primarily by health care professionals in the fields of orthopedics, neurovascular, surgery, vision care, diabetes care, infection

prevention, diagnostics, cardiovascular disease, sports medicine, and aesthetics. This segment is comprised of J&J’s Global Medical Solutions, Global Orthopedics and Global Surgery Groups. e.g.: LifeScan (One Touch)

1. Advanced Sterilization ProductsASP is a leader in infection prevention and markets a full range of innovative sterilization, disinfection and hand hygiene products that safely and effectively meet the needs of healthcare providers and patients worldwide. E.g.; STERRAD 100NX System, STERRAD NX, STERRAD 100S System.

2. Animas Corporation

Animas Corporation is

dedicated to making diabetes management easier through product innovation, exceptional customer support and customized education programs. Its mission is to improve the lifestyle of their patients, reduce the long-term morbidity of the disease and lower health care costs.

3. Biosense WebsterBiosense Webster, Inc., a J&J company, pioneered EP diagnostic catheters more than 20 years ago and continues to lead the industry

as an innovative provider of advanced cardiac diagnostic, therapeutic, and mapping tools. As the leader in EP navigation systems and ablation therapy, Biosense Webster, Inc. has technology that includes the largest installed base of cardiac mapping navigation systems worldwide in leading hospitals and teaching institutions. e.g.: Ablation Catheters, Diagnostic Catheters, Ultrasound Catheters, 3D Cardiac Mapping.

4. Cordis CorporationCordis Corporation is a

Consumer Franchise

OTC Pharmaceuticals

Skin Care

Baby Care

Women’s Health

Oral Care

Wound Care/& Nutritionals Others

Total Consumer Care Sales ($ in millions)

2013

4,028

3,704

2,295

1,568

1,622

1,480

14,697

2012

3,766

3,618

2,254

1,625

1,624

1,560

14,447

2011

3740

3715

2340

1792

1624

1672

14,883

2010

4549

3452

2209

1844

1526

1010

14,590

2009

5630

3467

2115

1895

1569

1127

15,803


worldwide leader in the development and manufacture of interventional vascular technology. Through the company’s innovation, research and development, Cordis partners with physicians worldwide to treat millions of patients who suffer from vascular disease. e.g.: FRONTRUNNER XP CTO catheter, PRECISE PRO RX carotid stent system.

5. DePuy Synthes Companies of J&JDePuy Synthes Companies of J&J is the largest, most innovative and comprehensive orthopedic and neurological business in the world, offering inspired solutions that go beyond quality implants and include services, education, instruments, and emerging technologies. e.g.: Locking Compression Plate System, Spine Cable System, Trauma - Bone Void Fillers.

6. Ethicon, Inc.

Ethicon believes in advancing surgical care worldwide to enhance patients’ lives. For more than 80 years, Ethicon has been a trusted partner, answering customers’ needs and delivering what is best for patients.

7. Ethicon Endo-Surgery, Inc.Ethicon Endo-Surgery develops and markets advanced medical

devices for minimally invasive and open surgical procedures. It focuses on procedure-enabling devices for the interventional diagnosis and treatment of conditions in general and bariatric surgery, as well as gastrointestinal health, gynecology and surgical oncology. e.g.: LAPRA-TY absorbable suture applier, Uterine Manipulator, ETHICON OMNEX Surgical Sealant

8. Johnson & Johnson Vision Care, Inc.J&J Vision Care, Inc., the world’s leading manufacturer of disposable contact lenses, is committed to transforming the world’s vision. Since its inception, it has strived to increase awareness of the importance of vision and vision care and to provide the world’s most exceptional vision correction options in the contact lens field. e.g.: Visine, Acuvue Brand Contact Lenses

9. LifeScan, Inc.LifeScan, Inc. is a leading maker of blood glucose monitoring systems for home and hospital use. The company is dedicated to improving the quality of life for people with diabetes through its One Touch® Products. e.g.: Hospital Products - Meters, Lancing Devices. (One Touch UltraMini, One Touch Ping).

10. MentorMentor business is a leading provider of products for the global aesthetics market, including breast implants and facial aesthetics and body contouring products. Ex: Saline Breast Implants, Tissue Expanders, PREVELLE Silk Dermal Filler, Liposuction Cannula.

11. Veridex LLCIt is dedicated to providing physicians with high-value in vitro diagnostic oncology products. Veridex products may significantly benefit patients through earlier disease detection and may enable personalized strategies to help improve patient management and outcomes

12. Ortho-Clinical Diagnostics, Inc.Ortho-Clinical Diagnostics, Inc. is a leading provider of high-value diagnostic solutions for the global health care community. Committed to developing the most advanced tests for early detection or diagnosis of disease, the company brings products to market that provide timely information and help to facilitate better medical decisions. Eg: Immunodiagnostic Systems - + VITROS 3600, Transfusion Medicine - + T. cruzi ELISA, ORTHO Scan System.


1.3.2.1 Revenue Generated by Medical & Diagnostics Device: [32][8]

1.3.3 Pharmaceuticals:The Pharmaceutical segment of J&J invested $5.3 billion in 2012 on research & development. The Janssen Pharmaceutical Companies of J&J are dedicated to addressing and solving the most important unmet medical needs of time, including oncology (e.g., multiple myeloma and prostate cancer), immunology (e.g., rheumatoid arthritis, irritable bowel disease and psoriasis), neuroscience

(e.g., schizophrenia, dementia and pain), infectious disease (e.g., HIV/AIDS, Hepatitis C and tuberculosis), and cardiovascular and metabolic diseases (e.g., diabetes). Driven by the commitment to patients, J&J develop

sustainable, integrated healthcare solutions by working side-by-side with healthcare stakeholders, based on partnerships of trust and transparency.

Janssen Diagnostics is committed to saving and improving patients’ lives through the integration and delivery of differentiating diagnostic and health IT solutions into world-

class personalized disease management. Building beyond their joint legacy of world-class diagnostic interventions, its mission is to invest and partner in driving revolutionary

diagnostic solutions in oncology, infectious diseases, and central nervous system diseases, immunologic and cardiovascular disease.

13. Janssen Diagnostics BWBA

Medical Device & Diagnostics Franchise ($ in millions)

Orthopedics

Surgical care

Vision care

Diabetes care

Specialty Surgery

Diagnostics

Cardiovascular care

Infection Prevention/Other

Total Medical Devices & Diagnostics Sale

2013

9,509

6,269

2,937

2,309

2,592

1,885

2,077

912

28,490

2012

7799

6648

2996

2616

2526

2069

1985

952

27,426

2012

7799

6648

2996

2616

2526

2069

1985

952

27,426

2011

5809

6637

2916

2652

2407

2164

2288

906

28,779

2010

5565

6272

2680

2470

2186

2053

2552

803

24,601


1. Janssen R&D LLCJanssen Pharmaceutical Companies, strategy is to identify the biggest unmet medical needs and match them with the best science, internal or external, to find solutions for patients worldwide. J&J leverage their world-class discovery and development expertise, and operational excellence, to bring innovative, effective treatments in five therapeutic areas: cardiovascular and metabolism; immunology; infectious diseases and vaccines; neuroscience, and oncology.

2. Janssen Pharmaceuticals Inc.Providing medicines for an array of health concerns in several therapeutic areas, including: attention deficit hyperactivity disorder (ADHD), general medicine (acid reflux disease, infectious diseases), mental health (bipolar I disorder, schizophrenia), neurologics (Alzheimer’s disease, epilepsy, migraine prevention and treatment), pain management, and women’s health. Eg: RAZADYNE, TOPAMAX, RISPERIDAL, DURAGESIC.

3. Johnson & Johnson Pharmaceutical Research and DevelopmentIt is responsible for discovering and developing pharmaceutical drugs. It has research sites located in Raritan, New Jersey, Titusville, New Jersey, Spring House, Pennsylvania, La Jolla, California, Beerse, Belgium and Toledo, Spain. It was created in the year 2001through the merging of various research organizations including McNeil Pharmaceuticals, Janssen Research Foundation, Three Dimensional Pharmaceuticals, and the R. W. Johnson Pharmaceutical Research Institute. In addition to internal research and development activities it is also involved in publicly funded collaborative research projects, with other industrial and academic partners.[7]

4. Johnson & Johnson Consumer Companies, Inc.J&J Consumer Companies, Inc. engages in the research and development of products in the categories of baby’s skin, bath time, bedtime, playtime, and natural. The company

also provides products for newborns, babies, toddlers and mothers, including cleansers, skin care, moisturizers, hair care, diaper care, sun protection, and nursing products. It offers its products through food, drug, and mass retail stores in the United States. The company is based in Skillman, New Jersey. J&J Consumer Companies, Inc. operates as a subsidiary of J&J [8].

5. Johnson & Johnson Health Care Systems Inc.The company provides business support services to large health care clients, as well as access to parent J&J’s products. It operates through three divisions: contracting (resource and risk management), strategic account management, and supply chain (order management and distribution services). Its customers include managed care organizations, hospital groups, physician networks, pharmacies, and government customers. The company also provides e-business and supply management services for a number of fellow J&J subsidiaries.[9] It offers its logistic services to transport

Company recognizes the impact of serious conditions on people’s lives, and aim to empower people through disease awareness, education and access to quality care. Company’s research and development

strategy focuses on identifying medical needs, and harnessing the best science in the world, whether from J&J’s own laboratories, or through strategic relationships and collaborations.


cardiology, orthopedics, minimally invasive surgery, and diagnostics products that are used to diagnose and treat patients with serious life threatening and debilitating diseases. The company is based in Piscataway, New Jersey. J&J Health Care Systems Inc. operates as a subsidiary of J&J [10].

6. McNeil Consumer HealthcareIt is a medicals products company belonging to the J&J healthcare products group. In 1904, one of McNeil’s sons, Robert Lincoln McNeil, became part of the company and together they created

McNeil Laboratories in 1933. The company is located in Fort Washington, PA, and currently employs 2,600 people. Known as the “JV,” this 50/50 joint venture between J&J and Merck handles the OTC product lines Pepcid, Mylanta, and Mylicon and is located at the McNeil Consumer Healthcare headquarters in Fort Washington, PA. In September 2011, however, the JV ended, when Merck sold its 50 percent interest in the joint venture. All former J&J-Merck products are now handled by McNeil Consumer Healthcare [11].

7. NeutrogenaNeutrogena is an American brand of skin care, hair care and

cosmetics that is headquartered in Los Angeles, California. Neutrogena products are distributed in more than 70 countries. Neutrogena was founded in 1930 by Emanuel Stolaroff, and was originally a cosmetics company named Natone. It is now part of the United States-based J&J conglomerate, which bought the independent company in 1994. J&J’s international network helped Neutrogena boost its sales and enter newer markets including India, South Africa, and China. The products includes Body and bath product, Cleansers, Cosmetics, Hair products, Men’s skin care, Moisturizers [12].

1.3.3.1 Revenue Generated by Pharmaceutical Segment: [32][8]

Therapeutic Area

Immunology

Infectious diseases

Neurosciences

Oncology

Others

Total Pharmaceutical Sales

2013

9,190

3,550

6,667

3,773

4,945

28,125

2012

7,874

3,194

6,718

2,629

4,936

25,351

2011

6789

3189

6948

2048

5385

24368

2010

5398

3033

6644

1465

5856

22396


2. Product Details2.1 RECENTLY LAUNCHED PRODUCTS [10]

Consumer Healthcare Products

1. Aveeno baby Organic Harvest lotion.2. Aveeno Baby Eczema Therapy Moisturizing

Cream.3. Aveeno Smart Essentials Daily Nourishing

Moisturizer with SPF 30.4. Aveeno Ageless Vitality Elasticity Recharging

System Day SPF 305. Aveno Living Color preventing shampoo for

medium Thick hair6. Aveeno Positively Nourishing soothing 24-

Hour Body moisturizer7. Aveeno Positively Nourishing Hydrating body

wash8. Aveeno Pure Renewal Shampoo9. Clean & Clear Morning Burst Boost Body

wash10. Clean & Clear Morning Burst Fruit infusions

Facial reviving cleanser.11. Listerine Total Care Zero12. Lubriderm Men’s 3-in-1 fragrance Free Lotion13. Neutrogena Naturals Purifying Facial Cleanser14. Neutrongena Rapid wrinkle Repair Night

Moisturizer15. neutrogena Wet Skin Sunblock Spray SPF 5016. RoC Retinol Correxion sensitive Night Cream17. Splenda Essentials No Calorie Sweetner18. Splenda Essentials No Calorie Sweetner, 1

Gram of fiber19. Tylenol Precise Pain Relieving Cream

Prescription &Pharmaceutical

Products

1. E d u r a n t (rilpivirine)

2. X a r e l t o (rivaroxaban tablets)

3. Z y t i g a (abiraterone a c e t a t e ) Once-Dai ly Tablets.

Medical Devices &Diagnostics Products

1. Thermocool SF NAV Catheter with Curve Visualization

2. 1-day Acuvue Moist Brand Contact Lenses for Astigma Tism

3. Animas Vibe4. Carto 3 System5. Cell Search

Circulating Tumor Cell Test

6. Enseal G2 Super Jaw tissue Sealer

7. Ethicon Endo Surgery Generator

8. Exoseal Vascular Closure device

9. Harmonic Focus Long curved shears

10. One touch Delica Lancing System

11. One touch UltraMini blood Glucose Meter With Smart Code 25

12. Realize Adjustable Gastric Band C

13. Surgiflo Hemostatic Matrix Kit.


2.2 RECENT APPROVALS AND PIPELINE PRODUCT:

2.2.1 Approved in 2013 [12]

Therapeutic Area

Cardio Vascular & Metabolism

Infectious Diseases and Vaccines

Oncology

Product name

INVOKANA (Canagliflozin)

OLYSIO (US) Simeprevir

BRUVICA™ (US) (ibrutinib)

Indication Sought

Type-2 diabetes

Chronic Hepatitis C Virus

Previously treated Mantle Cell Lymphoma

2.2.2 Drugs in Registration phase [12]

Therapeutic Area

Infectious Disease & Vaccines

Oncology

Product name

Sirturo (EU) (Bedaquiline)

Simeprevir (EU)

Ibrutinib

Siltuximab

Indication Sought

Multi-drug resistant tuberculosis

Chronic Hepatitis C Virus

Previously treated ChronicLymphocytic Leukemia/Small

Lymphocytic LymphomaPreviously treated Mantle Cell

Lymphoma (EU)

Multicentric Castleman’sdisease


2.2.3 Pipeline Products

Planned Filings in 2014-2017 [13]

2.2.4 Pipeline Products under Phase Trials:

Product name

XARELTO (rivoroxaban)

INVOKANA (Canagliflozin)

STELARA(ustekinumab)

SIMPONI ARIA(golimumab)

SIMPONI (golimumab)

Sirukumab

Indication Sought

» Acute Coronary Syndrome» Stent Thrombosis for Acute Coronary Syndrome

» Chronic Heart Failure» Type-2 diabetes» Fixed dose combination with Metformin (IR)» Fixed dose combination with Metformin (XR)

» Psoriatic Arthritis» Crohn’s Disease

Rheumatoid Arthritis (IV)

Ulcerative Colitis

Rheumatoid Arthritis

Therapeutic Area

Cardiovascular& Metabolism

Immunology

Therapeutic Area

Infectious Disease & Vaccines

Oncology

Immunology

Neuroscience

Product name

TMC647055/JNJ56914845(GSK 805)/Simeprevir

Daratumumab

Yondelis (US)

JNJ56021927/ARN-509

Sirkumab

Guselkumab

Esketamine

Indication Sought

Combinations for chronic Hepatitis C

Refractory multiple myeloma

2nd Line soft tissue sacroma

Pre-prostate cancer

Rhematoid Arthritis

Psoriasis

Treatment resistant depression


Therapeutic Area

Infectious Disease & Vaccine

Neuroscience

Oncology

Product name

SIRTURO (bedaquiline)

PREZISTA (darunavir) and cobicistat (GS-9350)

OLYSIO (simeprvir).

INVEGA (paliperidone ER OROS)

INVEGA SUSTENNA/XEP LION (paliperidone

palmitate IM longacting injectable)

INVEGA SUSTENNA/XEP LION (paliperidone

palmitate)

IMBRUVICA (ibrutinib)

JNJ56021927/AR N-509

Indication Sought

Multi-drug resistant tuberculosis

Fixed Dose combination HIV tablet for treatment naïve patients and treatment experienced patients

» Chronic Hepatitis C virus (HCV) infection for treatment naive patients

» Chronic Hepatitis C virus (HCV) infection for treatment experienced patients, relapsers, and non-responders

Pediatric indication- adolescent schizophernia

Schizophernia- 3 month injectable

Schizoaffective

» Relapsed/refractory patients with chronic Lymphocytic Leukemia (single agent) (randomized study PCYC-1112)

» Relapsed/refractory patients with chronic Lymphocytic Leukemia (single agent) (single arm phase-II study PCY-1102)

» Relapsed/refractory patients with chronic Lymphocytic Leukemia (in combination with Bendamustine and Ritumab) (randomized study CLL-3001)

» Treatment naive patients with chronic Lymphocytic Leukamia (single agent) (randomized study MCL-3001)

» Treatment naive patients with Mantle cell Lymphoma in combination with Bendamustine and Rituximab (randomized study MCL-3002)


Therapeutic Area Product name

Siltuximab

VELCADE (bortezomib)

YONDELIS (terabectedine)

ZYTIGA (abiraterone acetate)

Indication Sought

» Relapsed/refractory patients with Mantle Cell Lymphoma (single agent) (single arm phase II study PCYC-1104)

» Newly Diagnosed Non-Germinal Center B-cell Subtype of Diffuse Large B-cell Lymphoma in combination with R-CHOP (randomized study DBL-3001)

» Prostate Cancer non-metastatic castration-resistant

Multicentric Castleman’s Disease

Multiple Cell Lymphoma 1st line Multiple Myeloma Combination

» Soft tissue sacroma» Relapsed Ovarian Cancer

Prostate Cancer Newly Diagnosed Hormone Naïve Metastatic.


3. Patent Search Methodology

Considering the main objectives of reports, the innovation timeline of Johnson and Johnson patent applications were chosen whose priority date was from year 2008 to 2013 to observe the most recent growth in innovation. WIPO, USPTO, EPO and Patent Lens were chosen as the search database. Several databases require several search queries and give several numbers of results. To make the search queries,

Johnson and Johnson or J&J are considered as the applicant/ assignee and also duration between 2008 and 2013 is also mentioned.

The search in field combination of WIPO was done by using the keywords i.e., Johnson and Johnson in the applicant name or J&J and priority date range was 01.12.2008 to 01.12.2013. The above search query generated

Altogether, 744 patents were retrieved for analysis among which of them was taken from WIPO, USPTO and Patent Lens. Most of the patents were repeated in all three databases. Repetitions of patents or published applications were not considered and duplicate documents were removed. Altogether, 380 patents were retrieved for analysis and the number of patents from each database which were considered for analysis. After retrieval, the non-technical and technical information from the patents were collected and the raw data were represented in taxonomical

manner. These raw data were analyzed to evaluate the patenting activities over time, the number of patents over geographical scope, types of assignees, patent families and international patent classifications. Each and every patent was analyzed for getting the port folio of the company. Mind maps are created to signify the applications of inventions, patented products, and processes involved within the patents of Johnson and Johnson. After analyzing the patents only J&J vision care, consumer and few other subsidiaries are considered in this patent portfolio report.

Search query

Pa:(Johnson and Johnson) OR (Johnson & Johnson) and PD:[01.12.2008 to 1.12.2013]

a) Applicant/assignee: (Johnson and Johnson) OR (Johnson & Johnson)

b) Filed between 01.12.2008 to 01.12.2013

AN/Johnson and Johnson

Name of database

WIPO

Patent Lens

USPTO

Number of Patents

744

903

68


In this section, the patenting activities of J&J (recent five years), patent distributions under several International patent classification (IPC), contributions from the subsidiaries of J&J, geographical scope are discussed. The technical information such as applications of the inventions, products and compositions, processes involved with the inventions are also included in this section.

4. Result and Statistical Analysis

Figure: 3.1 Patenting Activities over timeline

BIBLIOGRAPHIC ANALYSIS3.1 PATENTING ACTIVITIES OVER TIME BY J&J

The priority years in which the patents have been filed by J&J is mentioned below:

The patenting activities of J&J depend on the first disclosure date of the inventions. The first disclosure date may be priority date or filing date. There may be more than one priority date when the inventions are

disclosed in more than one territory. The patenting activity of J&J is segregated into first disclosure date and second disclosure date (if applicable). Figure 2 demonstrates the patenting activities over time.

12

2008

174

2010

35

2012

76

2009

36

2011

2

2014

No

of P

aten

ts

Priority Years


Johnson & Johnson group is branched in to several parts: Johnson & Johnson Vision Care, Johnson & Johnson Consumer Inc, etc. The contributions for the inventions

from each of these parts are recorded (Figure 3.2). Only those Divisions of Johnson & Johnson are considered which operates under trade name of Johnson and Johnson

Figure: 3.2 Contribution from J&J subsidiaries

The maximum contribution (64%) on invention is noticed from J&J Vision Care, Inc. followed by J&J Consumer Inc (33%) among other division of J&J which was 161 patents followed by consumer care division which was equal to 84. The other includes collaboration with university and other division of Johnson and Johnson.

3.2 CONTRIBUTION FROM JOHNSON & JOHNSON SUBSIDIARIES:

64%

33%

2% 1% 0%

Johnson & Johnson Vision Care, Inc.

Johnson & Johnson Consumer [Us]

Johnson & Johnson Do Brasil Ind E Com De Produtos Para Saude Ltda [Br]

Vanderbilt University Johnson & Johnson

Johnson & Johnson And PharmaceuticalsResearch And Development Us

The inventions which are published on or after 2008 were first filed on or before 2008. The patenting record shows that the filing activity from 2008 which gradually increases up to 2010 followed by a decline from 2010. Highest number of filing was recorded (174) in 2010 followed by 76 (2009), 36 (2011) and 35 (2012), respectively. In year 2013 it shows only 2 patent means that patents filed in year 2012-2013 are not yet published.


3.3 TOP INVENTORS FOR JOHNSON & JOHNSONMost of the top inventors for Johnson and Johnson were from vision care and consumer care division

Figure 3.3: Top Inventors for J&J

The above graph clearly shows that inventor Randall Pugh B. has been top inventor Johnson and Johnson in vision care division with 81 patent applications, followed by Loy Chong Jin from Consumer Healthcare Care division with 12 patent applications. Randall Pugh B. seems to be important scientist for J&J in vision care division.

69

10

12

7

9

66

55

Daly Susan

Andjelic Sasa

Michael J Fevola

Michael F Widman

Mahmood Khalid

Simarana Kaur

Gerligand Pierre

Loy Chong Jin

Randall B Pugh

Top Inventors of J&J

No of Patents


Figure: 3.4 Top IPC Classification Vs No of Patents

The above graph shows that G02C (76)Classification is the maximum times occurred which classifies to the field ophthalmology (vision care) followed by A61K (64) which relates to Human medical uses and C08G classification is the least occurred in patent which is used for macromolecular compounds. Several inventions are found under A61Q, A61L, C112, A45C, and C08G etc. which indicates a broad range of research works performed by J&J.

76

G02C

64

A61K

43

A61F

15

B29D

19

A61Q

11

A61L

10

B65D

7

C11D

6

A45C

4

A61M

4

C08G

No

of P

aten

ts

IPC

Top Ipc Classification In Patents

J&J Group in current studies deals mainly with vision care, consumer healthcare. So, the inventions of vision care and consumer healthcare care products must have one application- either useful for human. IPCs

are introduced to evaluate the fields such as applications, processes. In this section, the patent analysis is conducted with respect to IPC (Figure. 3.4).

3.4 PATENT DISTRIBUTION UNDER IPCS FOR JOHNSON & JOHNSON


IPC Classification

A61F

A61L

A61M

A61Q

B29D

B65D

C11D

Description

Filters implantable into blood vessels, Devices to prevent collapsing of, tubular structures of the body. Ex: stents.

Methods or apparatus for sterilization of materials or objects in general; Disinfection, sterilization of air.

Devices for introducing media into, or onto, the body, for taking media from the body, for producing or ending sleep Ex: Catheters

Use of cosmetics or similar toilet preparations.

Producing particular articles from plastics or from substances in a plastic state.

Containers for storage or transport of articles or materials, e.g. bags, barrels.

Detergent compositions; Use of single substances as detergents; Soap or Resin soaps; Recovery of glycerol.


3.5 GEOGRAPHICAL SCOPE OF THE PATENT FILED BY JOHNSON & JOHNSON

Geographical scope is region or the country in which patent has been filed first. The above chart clearly shows that the most number of patents have been filed in United States (276) patents only one patent have filed in this country. The number of patents filed in Europe (47), Canada (20) and China (11) and Brazil and Australia is only two patents. This shows most of the R&D work and of J&J is carried out in US. The jurisdictions of maximum patent are in US, Europe and China.

Figure: 3.5 Geographical Scope of Patents filed

Geographical Scope of Patents filed

US

Europe

Canada

China

Brazil

Australia76%

13%6%

3%1%

1%


TECHNICAL ANALYSIS

3.6 STATUS AND TYPE OF PATENTS BY JOHNSON & JOHNSONJ&J patents which were having priority date after 2008 were analyzed. In all J&J filed maximum 328 new patent inventions which were categorized into product, process and product process patent respectively.

Figure 3.6: Status and Types of patent filed by J&J

J&J filed maximum product patents (243) recently in vision care and consumer care divisions. Only 10% product patent has been granted to J&J in these five years. It means the rest of the patent applications are still under process of grant. The filing in process and product process patent were minimum, though the got 11 patents in together.

Published

Granted

Status of Patents

223

20

37

5

37

6

Product & ProcessProduct Process


3.7 APPLICATIONS OF THE PATENT INVENTIONS

Figure3.7: Applications of Patents

The above bar graph represents the field of inventions of the patents. The maximum patents are in the field of ophthalmology which is related to vision care. The number of patents in field Vision Care (ophthalmology) is 168. The patents which are related to health care and dermatology are 47 and 39 respectively. There are 6 patents which are related to pharmaceutical products. This show most of the inventions by J&J were meant for vision care and consumer health care which mostly include contact lens and cosmetics.

51%

27%

20%

2%

0%

Vision Care

Health Care

Dermatology

Drug delivery

Animal Care

Application of Patent


Figure 3.8: Division of J&J group

The company J&J is divided into three main divisions namely in the field of consumer goods, Pharmaceuticals and Diagnostics & medical devices. The consumer goods have products in the field of vision care, cosmetics and health care products. The Pharmaceutical products include drugs for treating neurological & Psychiatric disorders. The Diagnostic & Medical devices include products for orthopedics, cardiovascular diseases, coronary artery diseases and neurovascular disease.

Orthopaedics

Cardiovascular Disease

Coronary Artery Disease

Neurovascular Disease

VisionCare

HealthCare

Diagnostics& Medical

Devices

Johnson&

Johnson

ConsumerCare Cosmetic

PharmaceuticalR & D

Treatment ofNeurological &

PsycchiatricDisorders


Figure 3.9: Details of J&J Consumer Care Product

Coploymer

Cleanser

Surfactact

Monomer mix

Thickner

Stabilizer

Emulsifier

Plant Extract

Hydrogel

Esters

Neutralization

Polymerization

Blending

Stabilizing

Emusification

Thickening

Compositions ProcessInvolved

Johnson& JohnsonConsumerProducts

Ionic

NonIonnic


Figure 3.10 Details of Plant Extracts used in Cosmetics preparation

Lilium Candidum

ConsumerHealthcare

ProductCosmetics Plant

Extract

Lilium Martagon

SkinLightening

SkinWhitening

SkinMoisturizer

SkinCleanser

Lilium Serbla

Southern Wood

Paulownin

Blackberry

Cotinus Coggygria


Figure 3.11 Details of products of Vision Care division

MyopiaProgression

TreatingPresobyia

OpthalmicCompositions

OpthalmicLens

OpthalmicDevices

DeliverLight

Therapy

OpthalmicSolutions

OpthalmicCorrections

Free form of Opthalmic Lens

Opthalmic LensPrecursor

LiquidMeniscus Lens

Contact Lens

Storing & Dispensingof Opthalmic Lens

Apparatus for formingOpthalmic Lens

DispensingOpthalmic Drug

Disinfection of Opthalmic Lens

Lase Confocal Sensor

Determining thicknessof Opthalmic Lens

Measuring the wavefrontof Opthakmic Lens

VisionCare


The vision care products include ophthalmic lens, ophthalmic solutions, ophthalmic compositions, ophthalmic corrections, ophthalmic devices, prevention of myopia, Treatment of presobyia, delivery of light therapy. The ophthalmic devices includes storage and dispensing of ophthalmic lens, dispensing of ophthalmic drugs, apparatus for forming ophthalmic lens, Disinfecting of ophthalmic lens , Determination of thickness of ophthalmic lens and measuring the wave front of ophthalmic lens. The ophthalmic lens consists of ophthalmic precursor, liquid meniscus lens, contact lens and free form of ophthalmic lens.

Figure 3.12: Applications of Consumer Care Products

PersonalHygiene Health Care Consumer

Products Cosmetics Skin Care

Skin Lightening

Skin Infection

Anti-Aging

Anti Inflammatory

Acne

Skin Cleansing

Skin Dehydration

Moisturising

Skin Care Device


The consumer products include cosmetics and health care products. The cosmetic products include skin care products which are skin lightening, skin infection, anti aging, anti inflammatory, acne, skin cleansing, skin dehydration, skin care devices, moisturizing cream. The Health care products include personal hygiene products for women.


The SWOT analysis is a beneficial tool for strategy planning between a company and its environment. It outlines the internal assets of a company as well as its external factors by setting a framework for evaluation of strategy, position and the direction of a company. It is also useful for the strategic marketing planning, competitor evaluation, and business developments, current and future researches. It outlines

the internal assets of a company as well as its external factors.

5. SWOT Analysis

Although, it is an easy analysis tool to configure the strategy of a company, the analysis can depend on personal cognition and subjective position. Generally, strengths and weakness are considered as the internal factors whereas opportunities and threats are the external factors of a company. The internal structure of a company include infrastructure,

qualities of employee, financial assets, research and development while academic or industrial collaborations, domestic market, international markets, government policies, rules and regulations are considered as the external factors. Table 2 points out the strengths, weakness, opportunities and threats of Johnson and Johnson.


Table 2 SWOT Analysis of Johnson & Johnson

Strength

» Global Presence: J&J is one of the oldest consumer care and pharmaceutical company. It has higher customer satisfaction and strong research and development facilities also It has strong global presence by having 250 subsidiary companies with operations in more than 57 countries.[7]

» Baby Care Products: J&J is a trusted brand by mothers. It is the only company that provides a wide range of baby care products including: Baby Skin care, Bath time, Bed time, Natural.[14]

» Consumer Healthcare: Company provides a wide range of personnel healthcare and cosmetic products including: skin care, wound care & topical, oral healthcare. Women’s health, over-the-counter medicines, nutritionals and vision care. [15]

» Diversification: J&J expand to pharmaceuticals with purchase of McNeil Laboratories inc., Cilag and Janssen Pharmaceutical. Apart form that J&J also collaborates with other small and/or large companies to attain presence in other medical segments. [16]

» Pharmaceutical Products: The pharmaceutical segment of J&J handled by the Janssen Pharmaceuticals. Which develops new drugs for different categories including oncology, immunology, neuroscience, infectious disease, cardiovascular & metabolic diseases.[17]

Weakness

» Novel Pipeline Products: J&J has lacking novel product including some recently developed therapies, diagnostic devices, sanitary products, other skin care products.[18]

» High Dependency: J&J is a conglomerate

» J&J depends upon related contributory/merged companies also it is highly depending on Respiratory & CNS products. [19]

» Product Recall: Due to some purity problem J&J recalled 43 over-the-counter children’s medicine due to this in the year 2010 company faces huge loss. [20]

» Pricing Pressure: J&J facing pricing pressure for cut-off their branded products price, as there are other generics available in the market which may directly affected the growth and revenue of the company.


Opportunities

» Medical instruments: J&J It can expand and innovate its diagnostic and devices branch[35]

» Wide Range of Potential Cross-selling Opportunities – Johnson & Johnson is in a position to strategically develop a myriad of cross selling opportunities. Maximizing its balance between pharmaceuticals, diagnostics, and medical devices could result in increased revenues[34]

» Collaborations with research organizations to work on several fields beyond food technology. [35]

» Launching of products for economy class people and marketing in rural areas[14]

» As the company has huge revenue it has more opportunities for taking over more companies.

» Potential to Exploit Biologics Market – The addition of further biologics (e.g. therapeutic proteins, antibodies) to its portfolio can serve as a buffer as small molecule patents expire. [34]

Threats

» Strong global competition: J&J has strong global competitors which provides alternative and substitution products at lower prices. Lowering prices or upgrading marketing plans or packaging can make J&J more as a competitive force.

» Negative Impact of Recent Product Recalls: Johnson and Johnson have the misfortune of having to recall of more disease condition than 40 medicines recently. FDA inspectors required the company to recall the children’s medications after discovering the company had not looked into dozens of consumer complaints about “black or dark specks” in Tylenol and other products. The company stands to take a hit to its sterling reputation as congressional lawmakers are blasting the company’s competence and integrity. [21]

» The major threats can be the generic competitors which can produce the similar product at lower price.[35]


6. Competitive Intelligence

Competitive intelligence is a business tool of ethical gathering and refinement of data to make a strategic business decision for a company13. It is an analysis to the members about the early warning of opportunities and threats. It provides the estimations and views of market which can help a company to pick itself up. In this section, a

comparative analysis between J&J and its competitors in healthcare, vision care is made on the basis of the ranges of products, finance, research areas and future plans.

6.1PHARMACEUTICALS:

6.1.1 GlaxoSmithKline (GSK)Glaxosmithkline (GSK) is a British multinational company headquartered in London. The company’s main business sectors are pharmaceuticals, biologics, vaccines and consumer healthcare. The company was established by merger of Glaxo Wellcome plc and SmithKline Beecham plc in 2000. The company’s pharmaceutical business researches, develops and makes available medicines that treat a variety of serious and chronic disease. Medicines available or in development in a wide range of areas including: Infectious diseases, Cancer, Epilepsy, Heart disease, Asthma and chronic obstructive pulmonary disease and HIV/AIDS. [22]

6.1.2 Abbott LaboratoriesAbbott laboratories are an

American Pharmaceutical company. The company’s drug portfolio includes Humira a drug for rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn’s disease, moderate to sever chronic psoriasis and juvenile idiopathic arthritis; Norvic a treatment for HIV; Depakote and anticonvulsant drug; and Synthroid a synthetic thyroid hormone. Abbott also has a broad range of medical devices, diagnostics and immunoassay products as well as nutritional products. [23]

6.1.3Novartis:Novartis International AG is a Swiss multinational company based in Switzerland ranking number two in sales among the world-wide industry in 2010. In 1996 Ciba-Geigy merged with Sandoz, with the pharmaceutical and agrochemical divisions of both staying together to form Novartis. The Pharmaceuticals Division of Novartis is

recognized worldwide for the innovative products, services and solutions provide to patients, physicians and healthcare organizations. This growing business works to change the way medicine is practiced by following the science to deliver the right treatment to the right patient at the right time. The Pharmaceuticals Division researches, develops, manufactures, distributes and sells branded pharmaceuticals used to treat diseases and conditions across a variety of therapeutic areas, including: auto-immunity, cardiovascular, dermatology, infectious diseases, metabolism, neuroscience, oncology, ophthalmology, respiratory, rheumatology, and transplantation. [24]

6.1.4LillyLilly is an American global pharmaceutical company with headquarters located in United States. Among other specialties, Lilly was the first company


to mass-produce penicillin, the salk polio vaccine, and insulin, including one of the first pharmaceutical companies to produce human insulin using recombinant DNA. Lilly is also the world’s largest manufacturer and distributor of psychiatric medications. The company’s pharmaceutical sector deals with bone muscle joint, cardiovascular, diabetes,

endocrine, men’s health, neuroscience and oncology. [25]

6.1.5SanofiSanofi S.A is a French multinational pharmaceutical company headquartered in Paris, France. Sanofi engages in research and development, manufacturing and marketing of pharmaceutical products for sale

principally in the prescription market, the firm also develops over-the-counter medication. The company covers 7 major therapeutic areas including cardiovascular, central nervous system, diabetes, internal medicine, oncology thrombosis and vaccines. The company was formed as Sanofi-Aventis in 2004 by the merger of Aventis and Sanofi-Synthelabo. [26]

Company

Infrastructure & Revenue Generated

Product Ranges

Johnson & Johnson

US-basedcompany,generating

revenue USD65.03 billion

in 2013

Oncology,immunology,neuroscience,

Infectious disease,

cardiovascular & metabolic

diseases

GSK

UK-based company, USD 36.14 billion in

2012

Cardiology,dermatology,

endocrinology, family medicine,gastroenerology, genetic disease,

hematology,hepatology,

immunology,infectious disease,

musculoskeletal,nephrology, neurology,obstetrics, oncology,

otolaryngology, pediatrics/

neonatology,psychiatrics,pulmonaryrespiratory

disease,urology, vaccines

Abbott

US-based company,

Generating revenue USD

21.484 billion in 2013

Gastroenterology Women’s Health Cardiovascular

Pain/Central Nervous System

Respiratory Anti-Infectives

Novartis

Swiss-based company, generating

revenue USD 58.566

billion in 2012

Hypertension,Metabolic disorder,

Infectious disease,

neuroscience,oncology,

ophthalmology,respiratory,

rheumatology and

auto-immunity,transplantation

Lilly

US-based company,

Generating revenue USD 24.286 billion

In 2012

Oncology,cardiovascular,

diabetes, critical care,

neuroscience,men’s health andMusculoskeletal.

Sanofi

France-basedcompany, generating

revenue USD 45.291 billion in

2013

Diabetes, cancer,cardiovascular

disease, infectiousdiseases,

ophthalmology rare diseases & multiple

sclerosis, immunology &Inflammation


Table no 3. Competitive Analysis Table in Pharmaceuticals division

Company

Cardiovascular & Metabolism

Immunology

InfectiousDisease &Vaccine

Neuroscience

Oncology

Johnson & Johnson

Rivoroxaban,Canagliflozin

Ustekinumab,Golimumab,Sirukumab

Bedaquiline,darunavirsi,

meprvir

paliperidone ERORO,

Spaliperidone,palmitatepaliperidone

Acetateibrutinib,siltuximab,bortezomib,

terabectedine,abiraterone

acetate

GSK

Camicinal,Iosmapimod,

Retosiban,ronacaleret,darapladip

Tafenoquine

-

Firategrast,rilapladib,patrome

Trametinib,revolade/promacta,

dabrafenib,foretinib+,

trametinib + dabrafenib,

Tyverb/ Tykerb(lapatinib),

Votrient

Abbott

OmacorTricor

Teveten

Tarka

-

Luvox

-

Novartis

-

-

-

-

Afinitor,

Lilly

Evacertrapib

-

-

Edivaxetine,solanezumab

Ramucirumab,Necitumumab

Sanofi

Alirocumab,Kynamro

(mipomersen)

-

-

-

Fedratinib,jevtana

Pipeline Products


6.2 CONSUMER HEALTHCARE:

6.2.1GSKGlaxosmithkline (GSK) is a British multinational company headquartered in London. The company’s main business sectors are pharmaceuticals, biologics, vaccines and consumer healthcare. The company was established by merger of Glaxo Wellcome plc and SmithKline Beecham plc in 2000. Company brings dental health products, over-the-counter medicines and nutritional drinks to millions

of people. Many of company’s brands, such as Sensodyne, Panadol, Aquafresh and Nicorette/Niquitin are familiar around the world.[22]

6.2.2Procter & GambleProcter & Gamble (P&G) is an American multinational consumer goods company headquartered in down town Cincinnati United States. Its products includes Beauty segment grooming segment, Health care segment, Snacks & pet care segment, Fabric care & Home care segment, Baby care

& Family home care segment.[27]

6.2.3Reckitt BenckiserReckitt Benckiser plc is an Anglo-Dutch multinational consumer goods company headquartered in Slough, Bershire. It is a major producer of health, hygiene and home products. It was formed by merger of UK-based Reckitt & Colman plc and the Netherlands-based Benckiser NV. Reckitt Benckiser’s brands include Dettol, Strepsils, Veet, Air wick, Calgon, Clearsil, Cillit Bang, Durex, Lysol and Vanish. [28]

Table no 4. Competitive Analysis Table in Consumer Healthcare division

Company

Infrastructure & Revenuegenerated

Product Ranges

J&J

US-based multinational

pharmaceutical and consumer healthcarecompany, generating revenue USD 65.030

billion in 2013

Baby care, skin & hair care, wound

care & topical, oral health care, women’s

health, over-the counter medicines, nutritionals, vision

care.

GSK

UK-based pharmaceutical and consumer healthcare

company, generatingrevenue USD 36.14

billion in 2013

Nutritional, over-the-ounter, Dermatological,oral healthcare, cold and

flu, vitamins and naturals, analgesic and repiratory,

Nicotine replacementtherapy, gastrointestinal,

pain relief, eye care, weight, sports nutrition,

lucozade.

P&G

US-basedmultinational

consumer goodscompany, generating

revenue USD84.17 billion in 2013

Beauty segmentGroomingsegment,

Health care segment,

Snacks & pet care segment,

Fabric care & Home care segment, Baby care & Family home

care segment.

Reckitt Benckiser

Dutch-basedmultinational

consumer goodscompany,generating

revenue USD16.7 billion in 2013

Health, hygiene and home products.


6.3 DIAGNOSTICS & MEDICAL DEVICES

6.3.1 Siemens Aktiengeschaft:Siemens Aktiengeschaft is a German multinational engineering and electronics conglomerate company headquartered in Munich and Berlin. It is Europe’s largest engineering company and maker of medical diagnostics equipment and its medical health-care division. Siemen’s pricipal activities are in the fields of industry, energy, infrastructure and healthcare. The companies healthcare division active in Diagnostics IT, Hospital IT, Imaging Software, Hearing Instruments, Laboratory Diagnostics, Medical Imaging, Therapy Systems. [29]

6.3.2 Roche Diagnostics:Roche Ltd is a Swiss global healthcare companies that operates worldwide under two division pharmaceuticals and diagnostics. As a global leader in healthcare, Roche Diagnostics offers a broad portfolio of tools that help healthcare providers

in the prevention, diagnosis and management of diseases like HPV, HIV, hepatitis and diabetes as well as other medical conditions, such as fertility and blood coagulation. These products and services are used by researchers, physicians, patients, hospitals and laboratories worldwide to help improve people’s lives. The Roche diagnostics products portfolio includes: blood glucose meters for people with diabetes, point-of-care testing devices, high-throughput analyzers and state-of-the-art instruments and reagents. [30]

6.3.3 Abbott Laboratories:Abbott laboratories is an American global pharmaceuticals and healthcare products company. The company’s in vitro diagnostics business is a world leader in immunoassays and blood screening. Its broad range of medical tests and diagnostic instrument systems are used worldwide by hospitals, laboratories, blood banks, and physician offices to diagnose and monitor diseases such as HIV, hepatitis, cancer,

heart failure and metabolic disorders, as well as assess other important indicators of general health. Abbott Point-of-Care manufactures diagnostic products for blood analysis to provide health care professionals critical diagnostics information accurately and immediately at the point of patient care. Abbott also provides point-of-care cardiac assays to the emergency room.[23]

6.3.4 Becton Dickinson:Becton, Dickinson and company (BD) is an American medical technology company that serves healthcare institutions, life science researchers, clinical laboratories, industry and the general public. BD manufactures and sells a broad range of medical supplies, devices, laboratory equipment and diagnostic products. BD was one of the first companies to sell U.S.-made glass syringes. It was also a pioneer in the production of hypodermic needles. Today, BD is divided into three segments: BD Medical, BD Diagnostics and BD Biosciences. [31]


Table no 5. Competitive intelligence table for Diagnostics and Medical Devices

Company

Infrastructure & Revenuegenerated

Product Ranges

J&J

US-basedmultinational

medical devices,

pharmaceuticaland consumer

healthcarecompany,generating


in 2013

Orthopedics,neurological

disease, visioncare, diabetescare, infection

prevention,diagnostics,

cardiovasculardisease, andAesthetics.

Siemens

Germanmultinationalengineering

and electronicsconglomerate

company,generating


(2013)

Industry, energy,

infrastructure and healthcare.the companies

healthcaredivision activein diagnosticsit, hospital it,

imagingsoftware,hearing

instruments,laboratory

diagnostics,medical imaging,therapysystems

Roche

Swiss-basedglobal

healthcarecompany,generating


(2011)

Prevention,diagnosis and management

of diseases like HPV,

HIV, hepatitis and

diabetes

Abbott Laboratories

Americanpharmaceutical

s andhealthcareproductscompany,generating


(2012)

HIV, hepatitis,cancer, heartfailure andmetabolicdisorders

Becton Dickinson

Americanmedical

technologycompany,generating


in 2012

healthcareinstitutions,life scienceresearchers,

clinicallaboratories,industry andthe general

public.


In order to investigate the trend of filing year- we have evaluated the information of patent filing year from 2008. The patents which are published on or after 2008 must be filed on or before 2008. Considering this fact, we have conducted a statistical analysis on the first filing year which provides three noteworthy information such as 1 maximum number of filing of new inventions (first file) was recorded in 2010 and 2) after 2010; the trend of filing decline may be the invention which filed in last three year might be in process of publishing.

J&J has preferred to file the patent through the disclosure in USPTO which shows a compact market in US. J&J has been mostly focusing on vision care and consumer healthcare products. IPC classification of G02C, A61K occurred maximum time in patent applications which shows the patent was filed on vision care and consumer healthcare division most of the patent filed were product patent and around 30 patents had been granted to J&J in this time period. J&J is divided into three main divisions namely in the field of consumer goods, Pharmaceuticals and Diagnostics & medical devices. The consumer goods spread its roots in the field of vision care,

cosmetics and health care products. The Pharmaceutical products include drugs for treating neurological & Psychiatric disorders. The Diagnostic & Medical devices include products for orthopedics, cardiovascular diseases, coronary artery diseases and neurovascular disease. The consumer products include cosmetics and health care products. The cosmetic products include skin care products which are skin lightening, skin infection, anti aging, anti inflammatory, acne, skin cleansing, skin dehydration, skin care devices, moisturizing cream. The Health care products include personal hygiene products for women.

The strengths of the J & J are its strong market expansion and It has products in different fields like Pharmaceutical, Medical devices & Diagnostics, & Consumer Health Care which makes it strong. It has 250 subsidiaries which operate in 57 countries. The weakness lies in high product cost, which is not affordable to customers in developing countries, their revenue dependence on limited drugs and the patent expiring in upcoming years. The opportunities lie in taking over its smaller competitors companies and the company as huge annual revenue.

7. Conclusion

Johnson & Johnson is a global company which is also well-known for its extensive research quality in human health. To investigate the most current growth of Johnson & Johnson, we have focused on the patents which are having priority date between year 2008 to 2013 and it provides 328 patents. The detailed analysis of patent information shows that the trends of grant of patent during our selected time frame become low by Johnson & Johnson group during the said time frame.


They have to diversify it product range for different countries. The special attention to biologics seems to be great opportunity of J&J in exploring new market sectors. The threat lies from the generic companies which offer similar product to J&J which can results in diversion of its existing consumers.

As J&J group operates on vast portfolio, it has many competitors in world markets. Few of them are Procter & Gamble, Reckitt

Benckiser, Colgate and Alcon. All these competitors operates in different fields, some of the product of the competitors of J&J are Dettol, Colgate Flax, Strepsils, Clearsil, Oral B, Pampers etc. These brands are equally strong as Johnson and Johnson product brand. So there are always tough competitions from these competitors companies. J&J needs to focus on developing new technology and taking over its competitors to be world leading company.


[Online] http://www.j&J.com, about the company, Accessed on 25th January 2014

[Online] http://www.harrisinteractive.com, Johnson & Johnson ranks No.1 in national corporate reputation survey for seventh consecutive year; Accessed on 25th January 2014

Michael Santoli, Barron’s latest ranking of the companies most esteemed by investors highlights some familiar favorites, including No. 1-ranked Johnson & Johnson, 2008; Barron’s Cover

[Online] http://www.J&J.com, company features and company structure; accessed on 25th January 2014

[Online] http://www.j&j.com, company structure & products, consumer healthcare; Accessed on 25th January 2014

Annual Report 2012, 2011 & 2010

[Online] http://www.j&j.com, company structure & products, medical devices & diagnostics; Accessed on 25th January 2014

Annual Reports 2011 & 2012

[Online] http://www.j&j.com, company structure & products, Pharmaceuticals; Accessed on 25th January 2014

[Online] http://www.j&j.com, recent launced products; Accessed on 27th January 2014

[Online] http://www.j&j.com, recent launced products consumer healthcare products; Accessed on 27th January 2014

[Online] http://www.us-fda.com, Recent approved drugs; Accessed on 27th January 2014

[Online] Janssen Pharmaceutical Companies of Johnson & Johnson; Potential filings, 2013

Annual report 2012, 2011 & 2010

8. References


[online] http://www.j&j.com, consumer healthcare; Accessed on 27th January 2014

[online] http://www.j&j.com, about the products; Accessed on 27th January 2014

[Online] http://www.us-fda.com, recent approved products; Accessed on 25th January 2014

Andrew West, Johnson & Johnson analysis, 2008

Jim Muller, J&J: strength, weakness, opportunity & threats, 2008; The Motley Fool

[Online] http://www.johnsonandjohnson-mgt111hn1.wikispace.com, strength and weakness; Accessed on 25th January 2014

[Online] http://www.marketingteacher.com, SWOT analysis johnson & johnson; Acessed on 25th January 2014

[Online] http://www.gsk.com, About company, products details and company sector; Accessed on 28th January 2014

[Online] http://www.abbott.com, about company; Accessed on 28th January 2014

[Online] http://www.novartis.com, about company; Accessed on 28th January 2014

[Online] http://www.lilly.com, about company; Accessed on 28th January 2014

[Online] http://www.sanofi.com, about company; Accessed on 28th January 2014

[Online] http://www.pg.com, About company and business sectors; Accessed on 28th January 2014

[Online] http://www.rb.com, about company and business sector; Accessed on 28th January 2014

[Online] http://www.siemens.com, about the company & business sectors; Accessed on 28th January 2014

[Online] http://www.roche.com, about company and business sectors; Accessed on 28th January 2014


[Online] http://www.BD.com, about company and business sectors; Accessed on 28th January 2014

[Online] Johnson & Johnson 2013 Annual Report Accessed on 17th April 2014

[Online] http://www.jnj.com/sites/default/files/pdf/awards-and-recognitions.pdf Accessed on 17th April 2014

[Online] www.rsc.org/learn-chemistry/resources/.../SWOT_Case_Study.ppt Accessed on 17th April 2014

http://johnsonandjohnson-mgt111hn1.wikispaces.com/Strengths+and+Weaknesses Accessed on 17th April 2014

IIPTALaunch a Career. Be Awesome

[email protected]

iipta1 portfolio report (2008-2013) a patent portfolio is generated and analyzed of johnson &...

Documents